Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal

Persistence of latently infected cells in presence of Anti-Retroviral Therapy presents the main obstacle to HIV-1 eradication. Much effort is thus placed on identification of compounds capable of HIV-1 latency reversal in order to render infected cells susceptible to viral cytopathic effects and imm...

Full description

Bibliographic Details
Main Authors: Mateusz Stoszko, Elisa De Crignis, Casper Rokx, Mir Mubashir Khalid, Cynthia Lungu, Robert-Jan Palstra, Tsung Wai Kan, Charles Boucher, Annelies Verbon, Emily C. Dykhuizen, Tokameh Mahmoudi
Format: Article
Language:English
Published: Elsevier 2016-01-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396415302309
_version_ 1819174328052219904
author Mateusz Stoszko
Elisa De Crignis
Casper Rokx
Mir Mubashir Khalid
Cynthia Lungu
Robert-Jan Palstra
Tsung Wai Kan
Charles Boucher
Annelies Verbon
Emily C. Dykhuizen
Tokameh Mahmoudi
author_facet Mateusz Stoszko
Elisa De Crignis
Casper Rokx
Mir Mubashir Khalid
Cynthia Lungu
Robert-Jan Palstra
Tsung Wai Kan
Charles Boucher
Annelies Verbon
Emily C. Dykhuizen
Tokameh Mahmoudi
author_sort Mateusz Stoszko
collection DOAJ
description Persistence of latently infected cells in presence of Anti-Retroviral Therapy presents the main obstacle to HIV-1 eradication. Much effort is thus placed on identification of compounds capable of HIV-1 latency reversal in order to render infected cells susceptible to viral cytopathic effects and immune clearance. We identified the BAF chromatin remodeling complex as a key player required for maintenance of HIV-1 latency, highlighting its potential as a molecular target for inhibition in latency reversal. Here, we screened a recently identified panel of small molecule inhibitors of BAF (BAFi's) for potential to activate latent HIV-1. Latency reversal was strongly induced by BAFi's Caffeic Acid Phenethyl Ester and Pyrimethamine, two molecules previously characterized for clinical application. BAFi's reversed HIV-1 latency in cell line based latency models, in two ex vivo infected primary cell models of latency, as well as in HIV-1 infected patient's CD4+ T cells, without inducing T cell proliferation or activation. BAFi-induced HIV-1 latency reversal was synergistically enhanced upon PKC pathway activation and HDAC-inhibition. Therefore BAFi's constitute a promising family of molecules for inclusion in therapeutic combinatorial HIV-1 latency reversal.
first_indexed 2024-12-22T20:37:13Z
format Article
id doaj.art-63201ca417954753afb8c06cb24c4a67
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-12-22T20:37:13Z
publishDate 2016-01-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-63201ca417954753afb8c06cb24c4a672022-12-21T18:13:26ZengElsevierEBioMedicine2352-39642016-01-013C10812110.1016/j.ebiom.2015.11.047Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency ReversalMateusz Stoszko0Elisa De Crignis1Casper Rokx2Mir Mubashir Khalid3Cynthia Lungu4Robert-Jan Palstra5Tsung Wai Kan6Charles Boucher7Annelies Verbon8Emily C. Dykhuizen9Tokameh Mahmoudi10Department of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The NetherlandsDepartment of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The NetherlandsDepartment of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Center, PO Box 2040 3000CA, Rotterdam, The NetherlandsDepartment of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The NetherlandsDepartment of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The NetherlandsDepartment of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The NetherlandsDepartment of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The NetherlandsDepartment of Viroscience, Erasmus University Medical Center, PO Box 2040 3000CA, Rotterdam, the NetherlandsDepartment of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Center, PO Box 2040 3000CA, Rotterdam, The NetherlandsDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USADepartment of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The NetherlandsPersistence of latently infected cells in presence of Anti-Retroviral Therapy presents the main obstacle to HIV-1 eradication. Much effort is thus placed on identification of compounds capable of HIV-1 latency reversal in order to render infected cells susceptible to viral cytopathic effects and immune clearance. We identified the BAF chromatin remodeling complex as a key player required for maintenance of HIV-1 latency, highlighting its potential as a molecular target for inhibition in latency reversal. Here, we screened a recently identified panel of small molecule inhibitors of BAF (BAFi's) for potential to activate latent HIV-1. Latency reversal was strongly induced by BAFi's Caffeic Acid Phenethyl Ester and Pyrimethamine, two molecules previously characterized for clinical application. BAFi's reversed HIV-1 latency in cell line based latency models, in two ex vivo infected primary cell models of latency, as well as in HIV-1 infected patient's CD4+ T cells, without inducing T cell proliferation or activation. BAFi-induced HIV-1 latency reversal was synergistically enhanced upon PKC pathway activation and HDAC-inhibition. Therefore BAFi's constitute a promising family of molecules for inclusion in therapeutic combinatorial HIV-1 latency reversal.http://www.sciencedirect.com/science/article/pii/S2352396415302309HIVLatencyBAF complexChromatin remodelinglatency reversal agents
spellingShingle Mateusz Stoszko
Elisa De Crignis
Casper Rokx
Mir Mubashir Khalid
Cynthia Lungu
Robert-Jan Palstra
Tsung Wai Kan
Charles Boucher
Annelies Verbon
Emily C. Dykhuizen
Tokameh Mahmoudi
Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
EBioMedicine
HIV
Latency
BAF complex
Chromatin remodeling
latency reversal agents
title Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
title_full Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
title_fullStr Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
title_full_unstemmed Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
title_short Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
title_sort small molecule inhibitors of baf a promising family of compounds in hiv 1 latency reversal
topic HIV
Latency
BAF complex
Chromatin remodeling
latency reversal agents
url http://www.sciencedirect.com/science/article/pii/S2352396415302309
work_keys_str_mv AT mateuszstoszko smallmoleculeinhibitorsofbafapromisingfamilyofcompoundsinhiv1latencyreversal
AT elisadecrignis smallmoleculeinhibitorsofbafapromisingfamilyofcompoundsinhiv1latencyreversal
AT casperrokx smallmoleculeinhibitorsofbafapromisingfamilyofcompoundsinhiv1latencyreversal
AT mirmubashirkhalid smallmoleculeinhibitorsofbafapromisingfamilyofcompoundsinhiv1latencyreversal
AT cynthialungu smallmoleculeinhibitorsofbafapromisingfamilyofcompoundsinhiv1latencyreversal
AT robertjanpalstra smallmoleculeinhibitorsofbafapromisingfamilyofcompoundsinhiv1latencyreversal
AT tsungwaikan smallmoleculeinhibitorsofbafapromisingfamilyofcompoundsinhiv1latencyreversal
AT charlesboucher smallmoleculeinhibitorsofbafapromisingfamilyofcompoundsinhiv1latencyreversal
AT anneliesverbon smallmoleculeinhibitorsofbafapromisingfamilyofcompoundsinhiv1latencyreversal
AT emilycdykhuizen smallmoleculeinhibitorsofbafapromisingfamilyofcompoundsinhiv1latencyreversal
AT tokamehmahmoudi smallmoleculeinhibitorsofbafapromisingfamilyofcompoundsinhiv1latencyreversal